| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Q Abdool Karim, SS Abdool Karim, JA Frohlich, AC Grobler, C Baxter, ... science 329 (5996), 1168-1174, 2010 | 3060 | 2010 |
| Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic SSA Karim, QA Karim The lancet 398 (10317), 2126-2128, 2021 | 1370 | 2021 |
| Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... Nature 602 (7898), 654-656, 2022 | 1018 | 2022 |
| Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial L Van Damme, G Ramjee, M Alary, B Vuylsteke, V Chandeying, H Rees, ... The Lancet 360 (9338), 971-977, 2002 | 1005 | 2002 |
| Timing of initiation of antiretroviral drugs during tuberculosis therapy SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, A Gray, ... New England Journal of Medicine 362 (8), 697-706, 2010 | 928 | 2010 |
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies … GD Tomaras, NL Yates, P Liu, L Qin, GG Fouda, LL Chavez, AC Decamp, ... Journal of virology 82 (24), 12449-12463, 2008 | 821 | 2008 |
| Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies NA Doria-Rose, CA Schramm, J Gorman, PL Moore, JN Bhiman, ... Nature 509 (7498), 55-62, 2014 | 783 | 2014 |
| New SARS-CoV-2 variants—clinical, public health, and vaccine implications SS Abdool Karim, T de Oliveira New England Journal of Medicine 384 (19), 1866-1868, 2021 | 779 | 2021 |
| Health in South Africa: changes and challenges since 2009 BM Mayosi, JE Lawn, A Van Niekerk, D Bradshaw, SSA Karim, ... The lancet 380 (9858), 2029-2043, 2012 | 764 | 2012 |
| HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response SSA Karim, GJ Churchyard, QA Karim, SD Lawn the Lancet 374 (9693), 921-933, 2009 | 706 | 2009 |
| Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... Nature 593 (7857), 142-146, 2021 | 667 | 2021 |
| Integration of antiretroviral therapy with tuberculosis treatment SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, AL Gray, ... New England Journal of Medicine 365 (16), 1492-1501, 2011 | 639 | 2011 |
| The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners MN Lurie, BG Williams, K Zuma, D Mkaya-Mwamburi, GP Garnett, ... Sexually transmitted diseases 30 (2), 149-156, 2003 | 627 | 2003 |
| SARS-CoV-2 variants and ending the COVID-19 pandemic A Fontanet, B Autran, B Lina, MP Kieny, SSA Karim, D Sridhar The Lancet 397 (10278), 952-954, 2021 | 601 | 2021 |
| The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection ES Gray, MC Madiga, T Hermanus, PL Moore, CK Wibmer, NL Tumba, ... Journal of virology 85 (10), 4828-4840, 2011 | 591 | 2011 |
| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants MR Abrahams, JA Anderson, EE Giorgi, C Seoighe, K Mlisana, LH Ping, ... Journal of virology 83 (8), 3556-3567, 2009 | 493 | 2009 |
| The Lancet Commission on lessons for the future from the COVID-19 pandemic JD Sachs, SSA Karim, L Aknin, J Allen, K Brosbøl, F Colombo, GC Barron, ... The Lancet 400 (10359), 1224-1280, 2022 | 488 | 2022 |
| Achieving the health Millennium Development Goals for South Africa: challenges and priorities M Chopra, JE Lawn, D Sanders, P Barron, SSA Karim, D Bradshaw, ... The Lancet 374 (9694), 1023-1031, 2009 | 466 | 2009 |
| Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa MN Lurie, BG Williams, K Zuma, D Mkaya-Mwamburi, GP Garnett, ... Aids 17 (15), 2245-2252, 2003 | 445 | 2003 |
| Genital inflammation and the risk of HIV acquisition in women L Masson, JAS Passmore, LJ Liebenberg, L Werner, C Baxter, KB Arnold, ... Clinical Infectious Diseases 61 (2), 260-269, 2015 | 432 | 2015 |
Lynn MorrisNational Institute for Communicable DiseasesΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα nicd.ac.za
